PDL BioPharma | SC TO-I/A: Issuer tender offer statement (Amendment)
PDL BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
PDL BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | 4: Statement of changes in beneficial ownership of securities
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | EFFECT: Others
PDL BioPharma | EFFECT: Others
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PDL BioPharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data